BME | IXJ | BME / IXJ | |
Gain YTD | 6.565 | 7.659 | 86% |
Net Assets | 532M | 4.04B | 13% |
Total Expense Ratio | 1.10 | 0.40 | 275% |
Turnover | 29.00 | 5.00 | 580% |
Yield | 0.35 | 1.55 | 22% |
Fund Existence | 21 years | 24 years | - |
BME | IXJ | |
---|---|---|
RSI ODDS (%) | 2 days ago90% | 2 days ago82% |
Stochastic ODDS (%) | 2 days ago82% | 2 days ago64% |
Momentum ODDS (%) | 2 days ago82% | 2 days ago79% |
MACD ODDS (%) | 2 days ago86% | 2 days ago74% |
TrendWeek ODDS (%) | 2 days ago80% | 2 days ago76% |
TrendMonth ODDS (%) | 2 days ago76% | 2 days ago81% |
Advances ODDS (%) | 3 days ago77% | 2 days ago80% |
Declines ODDS (%) | 8 days ago80% | 5 days ago77% |
BollingerBands ODDS (%) | 2 days ago83% | 2 days ago64% |
Aroon ODDS (%) | 2 days ago74% | 2 days ago77% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MSTSX | 12.24 | 0.08 | +0.66% |
Morningstar Global Opportunistic Equity | |||
NBHRX | 15.13 | 0.01 | +0.07% |
Neuberger Berman Equity Income R3 | |||
BIPIX | 56.46 | -0.10 | -0.18% |
ProFunds Biotechnology UltraSector Inv | |||
GEMIX | 29.85 | -0.06 | -0.20% |
Goldman Sachs Emerging Markets Eq Instl | |||
MINHX | 45.75 | -0.30 | -0.65% |
MFS International Intrinsic Value R4 |
A.I.dvisor tells us that BME and DHR have been poorly correlated (+16% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BME and DHR's prices will move in lockstep.
Ticker / NAME | Correlation To BME | 1D Price Change % | ||
---|---|---|---|---|
BME | 100% | +0.64% | ||
DHR - BME | 16% Poorly correlated | -0.88% | ||
UNH - BME | 12% Poorly correlated | -0.02% | ||
ABBV - BME | 12% Poorly correlated | +1.19% | ||
ABT - BME | 10% Poorly correlated | +0.71% | ||
AMGN - BME | 9% Poorly correlated | +1.01% | ||
More |
A.I.dvisor indicates that over the last year, IXJ has been closely correlated with TMO. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if IXJ jumps, then TMO could also see price increases.